Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasiaCartilage oligomeric matrix protein in monitoring and prognostication of osteoarthritis and its utility in drug developmentInterleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritisNew biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment.Genome-wide linkage analysis of quantitative biomarker traits of osteoarthritis in a large, multigenerational extended family.Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysisPseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.Effects of Whole Body Vibration Exercise associated with Quadriceps Resistance Exercise on functioning and quality of life in patients with knee osteoarthritis: a randomized controlled trial.Early stages of osteoarthritis: the search for sensitive predictors.Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritisAntisense Reduction of Mutant COMP Reduces Growth Plate Chondrocyte Pathology.Intramuscular clodronate in erosive osteoarthritis of the hand is effective on pain and reduces serum COMP: a randomized pilot trial-The ER.O.D.E. study (ERosive Osteoarthritis and Disodium-clodronate Evaluation).
P2860
Q27687777-29000EF5-4A7F-43AB-9B70-81C8911179A9Q28648075-79E8829A-6E7E-40D3-BA26-13D7D76F82F2Q35041613-FCDC71B4-FA49-4098-871F-4FD3A4E66A7AQ36294719-A856605F-007D-435C-820A-346E5050BF95Q36310851-ED88438C-993F-4D0E-9435-B74DF7322CECQ36934059-4C304A1D-FDEC-492D-8C1F-183E2B047C76Q37277626-12F603C8-B162-47A1-A68E-FF656A4DFE1DQ37457066-824458AD-6AAA-4C35-9141-45C13C36BFD7Q37462448-6753465D-ACA4-42C1-B779-1FD242FEBD0EQ37946174-2FA330AF-3F34-49EC-905B-AFE19A47037CQ39735942-3A2C799C-3BDD-4BB0-A61C-0361E0F3D3E4Q41951850-BB1B4304-2FF4-4F63-BDDC-B371A6AC7EF8Q42118121-6368C240-3F68-4E5A-A49A-03CF48C79D84Q42514613-87382ABE-3B48-49A6-95B1-4FE2118A3170Q50322999-E02E65EE-8477-46AC-86AE-F25D69EF5242Q50984708-CF257298-2CD8-4E8A-BCA6-23E28E7DE637
P2860
Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Changes in serum cartilage mar ...... collagen gene COL2A1 mutation.
@en
type
label
Changes in serum cartilage mar ...... collagen gene COL2A1 mutation.
@en
prefLabel
Changes in serum cartilage mar ...... collagen gene COL2A1 mutation.
@en
P2093
P2860
P1476
Changes in serum cartilage mar ...... collagen gene COL2A1 mutation.
@en
P2093
Bleasel JF
Heinegård D
Holderbaum D
Moskowitz RW
P2860
P356
10.1002/1529-0131(199901)42:1<39::AID-ANR5>3.0.CO;2-Y
P577
1999-01-01T00:00:00Z